Optic Nerve Disorders Clinical Trial
Official title:
Choroidal Thickness in Optic Neuropathy
| NCT number | NCT02382627 |
| Other study ID # | 14-2348 |
| Secondary ID | |
| Status | Terminated |
| Phase | |
| First received | |
| Last updated | |
| Start date | March 2015 |
| Est. completion date | December 2018 |
| Verified date | October 2019 |
| Source | University of Colorado, Denver |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study plans to learn more about the thickness of the choroid in patients with optic neuropathy. The choroid is a layer of blood vessels that supplies oxygen and nourishment to the outer layers of the retina. Patients are being asked to be in this research study because they have optic neuropathy and are receiving care at the University of Colorado Hospital.
| Status | Terminated |
| Enrollment | 2 |
| Est. completion date | December 2018 |
| Est. primary completion date | December 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion criteria: - age greater than 18 years, - diagnosis of optic neuropathy, - willing and able to sign an informed consent. Exclusion criteria: - steroid use within the past 4 weeks, - inability to cooperate with optical coherence tomography (OCT) testing, - relevant ocular comorbidities in the affected or unaffected eye, such as - glaucoma, - uveitis, - optic nerve hypoplasia, - age related macular degeneration, - refractive error greater than 5 spherical diopters. |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Colorado Hospital | Aurora | Colorado |
| Lead Sponsor | Collaborator |
|---|---|
| University of Colorado, Denver |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Difference of the subfoveal and parafoveal choroidal thickness in affected and unaffected eye of the same patient. | 1 time |